Whole Genome Prediction for Preimplantation Genetic Diagnosis

April 8, 2015

Kumar et al 2015 Genome Medicine

Genome Medicine

Kumar A. Ryan A. Kitzman JO, Wemmer N, Snyder MW, Sigurjonsson S, Lee C, Banjevic M, Zarutskie PW, Lewis A, . Shendure J, Rabinowitz M. Genome Medicine 2015 Apr 8;7(1):35.

Whole Genome Prediction for Preimplantation Genetic Diagnosis

Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA

Nature Cancer Summary: ctDNA as an early predictor of therapy response

Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients

Combining Donor-derived Cell-free DNA Fraction and Quantity to Detect Kidney Transplant Rejection

Gschwend et al Overall survival by circulating tumor DNA status in patients with post-operative muscle-invasive urothelial carcinoma treated

Cell-free DNA screening for trisomies 21, 18, and 13 in pregnancies at low and high risk for aneuploidy with genetic confirmation.

Cell-free DNA screening for prenatal detection of 22q11.2 deletion syndrome

Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant

A Novel Donor-Derived Cell-Free DNA Assay for the Detection of Acute Rejection in Heart Transplantation

Association between total cell free DNA and SARS-CoV-2 in Kidney Transplant Patients: A Preliminary Study

Dd-cfDNA Shows High Sensitivity for the Diagnosis of Pancreas Graft Rejection in Simultaneous Pancreas-Kidney Transplantation

Experts Discuss Personalized ctDNA Assays to Predict Immunotherapy Response

BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on pa

Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of- opportunity study

Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizuma

Detection of molecular residual disease using personalized circulating tumor DNA assay in colorectal cancer patients undergoing resection of

Serial ctDNA detection using a personalized, tumor-informed assay in esophageal adenocarcinoma patients following resection

ctDNA Clearance and Radiographic Resolution of Disease in Response to Dual Checkpoint Inhibition in metastatic microsatellite stable colo...

CIRCULATE-Japan: Circulating tumor DNA-guided adaptive platform trials to refine adjuvant therapy for colorectal cancer

Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection